Literature DB >> 17488169

Adenoid cystic carcinoma of the Bartholin gland: an overview.

Francesca Maia Woida1, Alfredo Ribeiro-Silva.   

Abstract

Vulvar carcinoma is the fourth most frequently encountered malignancy of the female reproductive tract. Among vulvar neoplasms, 0.1% to 5% are of Bartholin gland origin. Primary adenoid cystic carcinoma of the Bartholin gland is very rare. To date, only about 60 cases have been reported in the world literature. Microscopic examination reveals a neoplasm of cribriform pattern composed of nests and columns of cells of bland appearance arranged concentrically around glandlike spaces filled with eosinophilic periodic acid-Schiff-positive diastase-resistant material. Immunohistochemically, the tumor cells express low-molecular-weight keratins, carcinoembryonic antigen, lysozyme, alpha1-antichymotrypsin, S100, and type IV collagen. Adenoid cystic carcinoma of the Bartholin gland is a slow-growing but locally very aggressive neoplasm with high capacity for recurrence. Perineural and lymphatic invasion is characteristic of this tumor and may explain its propensity for causing pain and recurrence. The treatment may range from simple local excision to radical vulvectomy, with or without partial to complete regional lymphadenectomy.

Entities:  

Mesh:

Year:  2007        PMID: 17488169     DOI: 10.5858/2007-131-796-ACCOTB

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

1.  Adenoid Cystic Carcinoma of Vulva-11 Years' Single-Institution Experience.

Authors:  Leena Rose Johnson; Rema Prabhakaran Nair; Suchetha Sambasivan; Rari P Mony; Jayapriya Gangadharan; Aswin Kumar; Iqbal M Ahamed
Journal:  J Obstet Gynaecol India       Date:  2016-09-19

Review 2.  Systemic therapies for salivary gland adenoid cystic carcinoma.

Authors:  Sosuke Sahara; Alexandra E Herzog; Jacques E Nör
Journal:  Am J Cancer Res       Date:  2021-09-15       Impact factor: 5.942

3.  [Pathoanatomical preparation and reporting of specimens from precancerous lesions and carcinomas of the vulva].

Authors:  L-C Horn; K Schierle; K Klostermann; H-G Schnürch; P Hantschmann
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

4.  Chemoradiotherapy with irinotecan (CPT-11) for adenoid cystic carcinoma of Bartholin's gland: A case report and review of the literature.

Authors:  Eriko Takatori; Tadahiro Shoji; Jiyu Miura; Satoshi Takeuchi; Toru Sugiyama
Journal:  Gynecol Oncol Case Rep       Date:  2012-12-14

5.  Adenoid Cystic Carcinoma of Bartholin's Gland Clinically Mimics Endometriosis, A Case Report.

Authors:  Mojgan Akbarzadeh-Jahromi; Fatemeh Sari Aslani; Navid Omidifar; Sedigheh Amooee
Journal:  Iran J Med Sci       Date:  2014-11

6.  A Case of Adenoid Cystic Carcinoma Mimicking a Bartholin Cyst and Literature Review.

Authors:  Siew Pei Goh; Brian McCully; Matthew Kyle Wagner
Journal:  Case Rep Obstet Gynecol       Date:  2018-03-26

7.  Adenoid Cystic Carcinoma of Bartholin's Gland: A Case Report with Emphasis on Surgical Management.

Authors:  Stephanie Verta; Corina Christmann; Christine E Brambs
Journal:  Am J Case Rep       Date:  2022-03-09

8.  Clinicopathologic and survival analysis of patients with adenoid cystic carcinoma of vulva: single-institution experience.

Authors:  Jun Zhu; Lina Yin; Qifeng Wang; Xiaohua Wu; Guihao Ke
Journal:  Int J Clin Oncol       Date:  2020-08-10       Impact factor: 3.402

9.  Interdisciplinary treatment of the patient with adenoid cystic carcinoma of the Bartholin's gland resulting in 15 years' survival: a case report and review of literature.

Authors:  Marek Nowak; Magdalena Rycel; Marian Szpakowski; Andrzej Kulig; Janusz Sobotkowski; Adam Dziki
Journal:  Prz Menopauzalny       Date:  2014-11-02

Review 10.  Adenoid Cystic Carcinoma/Basal Cell Carcinoma of the Prostate: Overview and Update on Rare Prostate Cancer Subtypes.

Authors:  Salvatore Cozzi; Lilia Bardoscia; Masoumeh Najafi; Andrea Botti; Gladys Blandino; Matteo Augugliaro; Moana Manicone; Federico Iori; Lucia Giaccherini; Angela Sardaro; Cinzia Iotti; Patrizia Ciammella
Journal:  Curr Oncol       Date:  2022-03-09       Impact factor: 3.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.